5.00 USD
↗ 0.16 (3.31%)LIVE (AS OF 10:04 AM EDT)
Impact BioMedical, Inc. (IBO) trades at $5.00 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Oct 5, 2026.
Open?$5.00
High?$5.41
Low?$4.81
Prev. Close?$4.84
Volume?6.6K
Avg. Volume?212.1K
VWAP?$5.15
Rel. Volume?0.03x
Bid / Ask
Bid?$4.75 × 200
Ask?$5.05 × 400
Spread?$0.30
Midpoint?$4.90
Valuation & Ratios
Market Cap?41.4M
Shares Out?8.5M
Float?11.7M
Float %?10.9%
P/E Ratio?52.41
P/B Ratio?3.84
EPS?$0.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Employees
8
Market Cap
41.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
HOUSTON, TX 77084
Phone: 585 232 1500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?85
Momentum?71
Short Sent.?61
Piotroski F-Score?0/9Weak
Altman Z-Score?3.56Safe
Confidence?40%Low
Short InterestLow
Short % of Float?4.50%Low
Short Interest?527.0K
Days to Cover?1.0
Free Float11.7M
Avg Daily Volume530.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?0.16Weak
Quick Ratio?0.13Weak
Cash Ratio?0.00Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score53/100
P/E?52.4PRICEY▾
Peers100
S&P11
P/B?3.84FAIR▾
Peers100
S&P46
P/S?1,181.47HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.5CHEAP▾
S&P97
EV/Sales?1,181.18HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?7.3%FAIR▾
Peers50
S&P24
ROA?4.7%FAIR▾
Peers50
S&P43
Cash Flow & Enterprise
FCF?$-508000
Enterprise Value?$41.3M
Fundamentals ratios updated end of day